LifeStance Health (LFST) Return on Capital Employed (2021 - 2026)

LifeStance Health has disclosed Return on Capital Employed across 6 years of filings, most recently posting 2.32% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 301.0% year-over-year to 2.32%; the TTM figure through Mar 2026 stood at 2.32% (up 301.0% YoY), while the FY2025 annual figure was 1.26%, up 294.0% from the prior year.
• Return on Capital Employed improved to 2.32% in Q1 2026, from 1.25% in the prior quarter.
• Over the last five years, Return on Capital Employed for LFST reached as high as 4.26% in Q3 2024 and fell as low as 11.06% in Q4 2022.
• The 5-year median for Return on Capital Employed is 1.68% (2024), against an average of 3.24%.
• Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 720 bps — and 2024, when it soared 1476 bps.
• A 5-year view of Return on Capital Employed shows it stood at 11.06% in 2022, then soared by 80 bps to 2.24% in 2023, then grew by 25 bps to 1.68% in 2024, then soared by 175 bps to 1.25% in 2025, then soared by 85 bps to 2.32% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 2.32%, 1.25%, and 0.37% for Q1 2026, Q4 2025, and Q3 2025 respectively.